Lexicon Pharmaceuticals
LXRX
#7133
Rank
NZ$1.12 B
Marketcap
NZ$2.52
Share price
-4.05%
Change (1 day)
4.60%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): NZ-$0.26

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$0.27. In 2025 the company made an earnings per share (EPS) of NZ-$0.25 an increase over its 2024 EPS that were of NZ-$1.14.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.265.18%
2025NZ-$0.25-78.13%
2024NZ-$1.14-20%
2023NZ-$1.4231.15%
2022NZ-$1.08-0%
2021NZ-$1.0810.91%
2020NZ-$0.98-145.08%
2019NZ$2.17-206.09%
2018NZ-$2.04-5.74%
2017NZ-$2.17-10.95%
2016NZ-$2.432640%
2015NZ-$0.08877-96.34%
2014NZ-$2.42-2.53%
2013NZ-$2.49-9.09%
2012NZ-$2.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
NZ$33.06-12,513.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$9.60-3,706.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$74.41-28,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
NZ-$10.37 3,793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$17.77-6,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.03551-86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ-$1.33 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.67-353.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ-$52.00 19,426.67%๐Ÿ‡บ๐Ÿ‡ธ USA